Silje Nord from the Genome variation group, Department of Genetics at the Institute for Cancer Research has been awarded a prestigious career grant from Helse Sør-Øst for the proposal "Making sense of GWAS data". The grant amounts to NOK 2 million per year and runs for 4 years.
Published in major journals, first or last author from Oslo University Hospital.
Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy
Ann Oncol, 29 Suppl 5, v109
An emerging focus on lipids in extracellular vesicles
Adv Drug Deliv Rev (in press)
Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial
Lancet, 395 (10228), 951-961